Skip Navigation

European Heart Journal 2002 23(12):913-916; doi:10.1053/euhj.2001.3127
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aschermann, M.
Right arrow Articles by Widimsky, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aschermann, M.
Right arrow Articles by Widimsky, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

I have an acute myocardial infarction: open my coronary artery, stent it and keep full flow!

M. Aschermanna and P. Widimskyb

a Department of Internal Medicine and Cardiovascular Center, General Teaching Hospital, 1st School of Medicine, Charles University, Prague, Czech Republic
b Cardiocenter, University Hospital, Vinohrady, Prague, Czech Republic

References

  1. Li RH, Herrmann HC. Facilitated percutaneous coronary intervention: A novel concept in expediting and improving acute myocardial infarction care. Am Heart J. 2000;140:S125–135[CrossRef][Web of Science][Medline]
  2. Weaver WD, Simes RJ, Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093–2098[Abstract/Free Full Text]
  3. Gibson CM, Cannon CHP, Murphy SA. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125–130[Abstract/Free Full Text]
  4. Tan WA, Moliterno D. TIMI flow and surrogate end points: What you see is not always what you get. Am Heart J. 1998;136:570–573[CrossRef][Web of Science][Medline]
  5. Armstrong PW, Collen D. Fibrinolysis for acute myocardial infarction. Current sattus and new horizons for pharmacological reperfusion, Part 1. Circulation. 2001;103:2862–2866[Free Full Text]
  6. Armstrong PW, Collen D. Fibrinolysis for acute myocardial infarction. Current status and new horizons for pharmacological reperfusion, Part 2. Circulation. 2001;103:2987–2992[Free Full Text]
  7. Gibson CM. Primary angioplasty compared to thrombolysis: New issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting. Ann Int Med. 1999;130:841–847[Abstract/Free Full Text]
  8. Antman EM, Giugliano RP, Gibson CM. Abciximab facilitates the rate and extent of thrombolysis. Results of the Thrombolysis in Myocardial Infarction (TIMI) 14 Trial. Circulation. 1999;99:2720–2732[Abstract/Free Full Text]
  9. Montalescot G, Barragan P, Wittenberg O. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001;344:1895–1903[Abstract/Free Full Text]
  10. Brodie BR, Stuckey TD, Hansen Ch, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol. 2000;85:13–18[Web of Science][Medline]
  11. Ross AM, Coyne KS, Reiner JS. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol. 1999;34:1954–1962[Abstract/Free Full Text]
  12. N Engl J Med. 1993;329:673–682[Abstract/Free Full Text]
  13. Lancet. 1994;343:311–322[CrossRef][Web of Science][Medline]
  14. N Engl J Med. 1997;337:1118–1123[Abstract/Free Full Text]
  15. Hearse DJ. Ischaemia, reperfusion and cardioprotection: successes and failures in the journey from molecule to man. Eur Heart J Supplements. 2001;3:C11–C21[Abstract]
  16. Brener SJ, Vrobel TR, Lopez JF. INTRO AMI: marked enhancement of arterial patency with eptifibatide and low dose t-PA in acute myocardial infarction (Abstr). Circulation. 1999;100:I-649
  17. Circulation. 2000;101:2788–2794[Abstract/Free Full Text]
  18. Marwick TH, Brunken R, Meland N. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single photon emission computed tomography: the Nycomed NC 100100 Investigators. J Am Coll Cardiol. 1998;32:1260–1269[Abstract/Free Full Text]
  19. de Lemos JA, Antman EM, Gibson CM. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from TIMI 14 trial. Circulation. 2000;101:239–243[Abstract/Free Full Text]
  20. Eur Heart J. 2000;21:2005–2013[Abstract/Free Full Text]
  21. Antman EM, Cooper HA, Gibson CM. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II. Eur Heart J. 2002;23:928–933[Abstract/Free Full Text]
  22. Lancet. 2001;357:1905–1914[CrossRef][Web of Science][Medline]
  23. Lancet. 2001;358:605–613[CrossRef][Web of Science][Medline]
  24. Alonso, A, Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction
  25. Vermeer F, Oude Ophius AJ, Van den Berg EJ. Prospective randomized comparison between thrombolytics, rescue PTCA and primary PTCA in patients with extensive myocardial infarction admitted to the hospital without PTCA facilities: a safety and feasibility study. Heart. 1999;82:426–431[Abstract/Free Full Text]
  26. Widimský P, Groch L, elízko M, Aschermann M, Bedná F, Suryapranata H. Multicenter randomized trial comparing transport to primary angioplasty vs. Immediate thrombolysis vs. Combined strategy for patients with acute myocardial infarction presenting to a community hospital without catheterization laboratory. Eur Heart J. 2000;21:823–831[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aschermann, M.
Right arrow Articles by Widimsky, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aschermann, M.
Right arrow Articles by Widimsky, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?